EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activity Against ESKAPE Bacterial Pathogens of Pyrazole-Indol-Ruthenium(II) Complexes

Yahaira Cuenú-Ibargüen iD, Andrés Restrepo-Acevedo iD, Juan Felipe Zambrano-Bedoya iD, Isabel Murillo-Rodriguez, Carlos Felipe Mejía, Sandra Fabiola Alzate-Walteros, Gladymar Guadalupe Valenzuela-Ramirez iD, Gilmar López-Armenta iD, Federico Del Rio-Portilla, Jesús Ricardo Parra-Unda iD, Fernando Cuenú-Cabezas iD, Ronan Le Lagadec iD

Antibiotics · 09.07.2026 · 15 (7) · 675

DOI: 10.3390/antibiotics15070675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 09.07.2026. Verfasst von Yahaira Cuenú-Ibargüen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior s/n, Ciudad Universitaria, Ciudad de México 04510, Mexico. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Nacional Autónoma de México, University of Quindío, Ministry of Sciences, Humanities, Technology and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper presents the synthesis and characterization of Schiff base ligands (L) derived from NH-pyrazole-indole and their ruthenium(II) complexes of the general formula [Ru(p-cymene)(L)Cl2]. The structural characterization of the ligands and ruthenium complexes was performed using a range of analytical methods, including infrared spectroscopy (IR), Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, ultraviolet-visible (UV-Vis) spectroscopy, elemental analysis, mass spectrometry(ESI-MS), density functional theory (DFT) calculations, and single-crystal X-ray diffraction crystallography for two of the four synthesized compounds. Schiff base ligands (L) derived from NH-pyrazole-indole and their ruthenium(II) complexes were evaluated against antibiotic-resistant bacteria. The effect of substituting the ligand with methoxy groups on biological activity was assessed. The antibacterial activity, Minimal Inhibitory Concentration (MIC), and Minimal Bactericidal Concentration (MBC) of the free ligands and the ruthenium compounds were measured against six bacterial isolates (Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, Shigella dysenteriae) and two control strains (Enterococcus faecalis ATCC 29212 and Enterobacter cloacae ATCC 13047) from the ESKAPE group of highly antibiotic-resistant pathogens. The free ligands were inactive, whereas all four ruthenium complexes displayed notable antibacterial activity. In particular, compounds Ru3 and Ru4 exhibited higher activity against Staphylococcus aureus than the Trimethoprim control, with MIC values of 15.60 µg/mL, compared with an MIC > 64 µg/mL for Trimethoprim. The activity of those two complexes was similar to that of Gentamicin against this strain. Molecular docking calculations suggested a possible mechanism of action through binding of the complexes to the active site of S. aureus PBP2a.

Schlagwörter

Stichwörter der Autor:innen

DFTESKAPE pathogensMolecular docking calculationsPyrazole-indole ligandsRutheniumSchiff bases

Autor:innen und Institutionen

  • Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior s/n, Ciudad Universitaria, Ciudad de México 04510, Mexico.
  • Programa de Química, Facultad de Ciencias Básicas y Tecnologías, Universidad del Quindío, Carrera 15 Calle 12 Norte, Armenia 630004, Quindío, Colombia.
  • Unidad de Investigaciones en Salud Pública "Dra Kaethe Willms", Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Ciudad Universitaria, Culiacán 80013, Sinaloa, Mexico.

ORCID-Profile: Yahaira Cuenú-Ibargüen, Andrés Restrepo-Acevedo, Juan Felipe Zambrano-Bedoya, Gladymar Guadalupe Valenzuela-Ramirez, Gilmar López-Armenta, Jesús Ricardo Parra-Unda, Fernando Cuenú-Cabezas, Ronan Le Lagadec

Förderung

  • Universidad Nacional Autónoma de México
  • University of Quindío
  • Ministry of Sciences, Humanities, Technology and Innovation
  • PAPIIT
  • Universidad del Quindío
  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación

Zitieren

APA

Cuenú-Ibargüen, Y., Restrepo-Acevedo, A., Zambrano-Bedoya, J. F., Murillo-Rodriguez, I., Mejía, C. F., Alzate-Walteros, S. F., Valenzuela-Ramirez, G. G., López-Armenta, G., Del Rio-Portilla, F., Parra-Unda, J. R., Cuenú-Cabezas, F., & Le Lagadec, R. (2026). Activity Against ESKAPE Bacterial Pathogens of Pyrazole-Indol-Ruthenium(II) Complexes. Antibiotics, 15(7), 675. https://doi.org/10.3390/antibiotics15070675

Vancouver

Cuenú-Ibargüen Y, Restrepo-Acevedo A, Zambrano-Bedoya JF, Murillo-Rodriguez I, Mejía CF, Alzate-Walteros SF, et al. Activity Against ESKAPE Bacterial Pathogens of Pyrazole-Indol-Ruthenium(II) Complexes. Antibiotics. 2026;15(7):675. doi:10.3390/antibiotics15070675

BibTeX
@article{CuenIbargen2026,
  author = {Cuenú-Ibargüen, Yahaira and Restrepo-Acevedo, Andrés and Zambrano-Bedoya, Juan Felipe and Murillo-Rodriguez, Isabel and Mejía, Carlos Felipe and Alzate-Walteros, Sandra Fabiola and Valenzuela-Ramirez, Gladymar Guadalupe and López-Armenta, Gilmar and Del Rio-Portilla, Federico and Parra-Unda, Jesús Ricardo and Cuenú-Cabezas, Fernando and Le Lagadec, Ronan},
  title = {Activity Against ESKAPE Bacterial Pathogens of Pyrazole-Indol-Ruthenium(II) Complexes},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {675},
  doi = {10.3390/antibiotics15070675}
}
Kostenlos starten →